JMP Securities analyst David Turkaly lowered the firm’s price target on Lantheus to $100 from $130 and keeps an Outperform rating on the shares. Lantheus delivered an upside print, with PYLARIFY continuing to lead the way, producing $215.4M in sales, while DEFINITY also contributed nicely at $67.3M, the analyst tells investors in a research note. Management noted that it saw consistent weekly dosing demand for PYLARIFY in June, July, and August, and then saw a step-up in September that also carried over into October, the firm says.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LNTH:
- Lantheus Reports Third Quarter 2023 Financial Results
- Lantheus raises FY23 adjusted EPS view to $5.80-$5.85 from $5.60-$5.70
- Lantheus reports Q3 adjusted EPS $1.47, consensus $1.32
- Lantheus price target lowered to $100 from $110 at Truist
- William Blair biotech analyst to hold an analyst/industry conference call
Questions or Comments about the article? Write to editor@tipranks.com